Peptilab presents Cagrilintide, a promising amylin-analog currently under development for weight management applications. This compound shows particular potential when combined with GLP-1 agonists for enhanced appetite suppression effects.
As a research-grade material, Peptilab's Cagrilintide demonstrates excellent purity (>99%) and comes in lyophilized powder form. The white, solid compound maintains stability when stored properly in dry, dark conditions.
The mechanism of action involves appetite regulation pathways, making it a valuable compound for metabolic research. Early studies suggest significant weight reduction potential through its unique biological activity.
Peptilab maintains strict quality control measures throughout production to ensure batch-to-batch consistency. Our technical team specializes in peptide synthesis and optimization to deliver premium research materials.
Note: This product is intended for research purposes only, not for human consumption. Proper handling procedures should be followed by qualified researchers.